Factors that Impact Susceptibility to Fiber-Induced Health Effects
暂无分享,去创建一个
J. Testa | J. Below | N. Fukagawa | A. Hirvonen | N. Cox
[1] Sergio Pina Oviedo,et al. Diffuse malignant mesothelioma. , 2012, Archives of pathology & laboratory medicine.
[2] A. Hjerpe,et al. Adaptation of a commercial fluorescent in situ hybridization test to the diagnosis of malignant cells in effusions. , 2010, Lung cancer.
[3] M. L. Calle,et al. Genetic susceptibility to distinct bladder cancer subphenotypes. , 2010, European urology.
[4] M. Mencoboni,et al. Risk of malignant pleural mesothelioma and polymorphisms in genes involved in the genome stability and xenobiotics metabolism. , 2009, Mutation research.
[5] F. Gemignani,et al. Polymorphisms in the putative micro-RNA-binding sites of mesothelin gene are associated with serum levels of mesothelin-related protein , 2009, Occupational and Environmental Medicine.
[6] R. Sobti,et al. Impact of interaction of polymorphic forms of p53 codon 72 and N-acetylation gene (NAT2) on the risk of lung cancer in the North Indian population. , 2009, DNA and cell biology.
[7] P. D. Dal Cin,et al. Cytogenetics and fluorescence in situ hybridization as adjuncts to cytology in the diagnosis of malignant mesothelioma , 2009, Cancer.
[8] D. Sugarbaker,et al. Institutional report - Thoracic oncologic Chromosomal deletion in patients with malignant pleural mesothelioma , 2009 .
[9] A. Nicholson,et al. CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma—A miRNA microarray analysis , 2009, Genes, chromosomes & cancer.
[10] B. Mittal,et al. Association of NAT2 gene polymorphisms with susceptibility to esophageal and gastric cancers in the Kashmir Valley. , 2009, Archives of medical research.
[11] T. Woyengo,et al. Anticancer effects of phytosterols , 2009, European Journal of Clinical Nutrition.
[12] G. Serio,et al. Characterization of a complex chromosome aberration in two cases of peritoneal mesothelioma arising primarily in the hernial sac , 2009, Pathology international.
[13] P. Valberg,et al. Ionizing radiation: a risk factor for mesothelioma , 2009, Cancer Causes & Control.
[14] R. Stahel,et al. Functional inactivation of NF2/merlin in human mesothelioma. , 2009, Lung cancer.
[15] N. Freedman,et al. Sex Disparities in Cancer Incidence by Period and Age , 2009, Cancer Epidemiology Biomarkers & Prevention.
[16] J. Testa,et al. Activated TNF-α/NF-κB signaling via down-regulation of Fas-associated factor 1 in asbestos-induced mesotheliomas from Arf knockout mice , 2009, Proceedings of the National Academy of Sciences.
[17] J. Buring,et al. Dietary intake of selected flavonols, flavones, and flavonoid-rich foods and risk of cancer in middle-aged and older women. , 2009, The American journal of clinical nutrition.
[18] R. Lucito,et al. Genomic events associated with progression of pleural malignant mesothelioma , 2009, International journal of cancer.
[19] Pär Sparén,et al. Occupation and cancer – follow-up of 15 million people in five Nordic countries , 2009, Acta oncologica.
[20] J. Herman,et al. Cruciferous Vegetable Consumption and Lung Cancer Risk: A Systematic Review , 2009, Cancer Epidemiology Biomarkers & Prevention.
[21] K. Lillycrop,et al. Horizons in Nutritional Science , 2022 .
[22] J. Y. Kim,et al. Garlic intake and cancer risk: an analysis using the Food and Drug Administration's evidence-based review system for the scientific evaluation of health claims. , 2009, The American journal of clinical nutrition.
[23] F. Ricceri,et al. Survival of pleural malignant mesothelioma in Italy: A population‐based study , 2009, International journal of cancer.
[24] T. Oury,et al. North american erionite-associated mesothelioma with pleural plaques and pulmonary fibrosis: a case report. , 2009, International journal of clinical and experimental pathology.
[25] J. Testa,et al. A novel mechanism of late gene silencing drives SV40 transformation of human mesothelial cells. , 2008, Cancer research.
[26] S. Levin,et al. Environmental exposure to Libby Asbestos and mesotheliomas. , 2008, American journal of industrial medicine.
[27] F. Galateau-Sallé,et al. Prognostic significance of p16/cdkn2a loss in pleural malignant mesotheliomas , 2008, Virchows Archiv.
[28] E. Mcconnell,et al. A review of carcinogenicity studies of asbestos and non-asbestos tremolite and other amphiboles. , 2008, Regulatory toxicology and pharmacology : RTP.
[29] J. Herman,et al. Carotenoids and the risk of developing lung cancer: a systematic review. , 2008, The American journal of clinical nutrition.
[30] Z. Herceg,et al. Epigenetic drivers and genetic passengers on the road to cancer. , 2008, Mutation research.
[31] Z. Herceg,et al. Epigenetic interplay between histone modifications and DNA methylation in gene silencing. , 2008, Mutation research.
[32] S. Bonassi,et al. Genetic susceptibility to malignant pleural mesothelioma and other asbestos-associated diseases. , 2008, Mutation research.
[33] H. Pass,et al. The relationship between simian virus 40 and mesothelioma , 2008, Current opinion in pulmonary medicine.
[34] Y. C. Lee,et al. Textbook of Pleural Diseases , 2008 .
[35] Simion I. Chiosea,et al. Diagnostic importance of 9p21 homozygous deletion in malignant mesotheliomas , 2008, Modern Pathology.
[36] K. Golka,et al. N-Acetyltransferase-2 and Medical History in Bladder Cancer Cases with a Suspected Occupational Disease (BK 1301) in Germany , 2008, Journal of toxicology and environmental health. Part A.
[37] D. Löhlein,et al. N-Acetyltransferase 1 in Colon and Rectal Cancer Cases from an Industrialized Area , 2008, Journal of toxicology and environmental health. Part A.
[38] M. J. van de Vijver,et al. A conditional mouse model for malignant mesothelioma. , 2008, Cancer cell.
[39] S. Bonassi,et al. Genetic susceptibility to malignant mesothelioma and exposure to asbestos: the influence of the familial factor. , 2008, Mutation research.
[40] D. Berman,et al. A Meta-Analysis of Asbestos-Related Cancer Risk That Addresses Fiber Size and Mineral Type , 2008, Critical reviews in toxicology.
[41] 谷口 哲郎. Genomic profiling of malignant pleural mesothelioma with array-based comparative genomic hybridization shows frequent non-random chromosomal alteration regions including JUN amplification on 1p32 , 2008 .
[42] H. Pass,et al. Soluble mesothelin-related peptide level elevation in mesothelioma serum and pleural effusions. , 2008, The Annals of thoracic surgery.
[43] BTS statement on malignant mesothelioma in the UK, 2007 , 2007, Thorax.
[44] A. Chella,et al. Clinical Significance of Serum Mesothelin in Patients with Mesothelioma and Lung Cancer , 2007, Clinical Cancer Research.
[45] C. Porta,et al. Erionite and asbestos differently cause transformation of human mesothelial cells , 2007, International journal of cancer.
[46] M. Mencoboni,et al. Polymorphisms of glutathione‐S‐transferase M1 and manganese superoxide dismutase are associated with the risk of malignant pleural mesothelioma , 2007, International journal of cancer.
[47] M. Musti,et al. Mesothelioma in blood related subjects: report of 11 clusters among 1954 Italy cases and review of the literature. , 2007, American journal of industrial medicine.
[48] S. Skates,et al. Soluble mesothelin in effusions: a useful tool for the diagnosis of malignant mesothelioma , 2007, Thorax.
[49] E. Ampleford,et al. Identification of a mesothelioma phenotype. , 2007, Respiratory medicine.
[50] H. Tagawa,et al. Genomic profiling of malignant pleural mesothelioma with array‐based comparative genomic hybridization shows frequent non‐random chromosomal alteration regions including JUN amplification on 1p32 , 2007, Cancer science.
[51] H. Pass,et al. A mesothelioma epidemic in Cappadocia: scientific developments and unexpected social outcomes , 2007, Nature Reviews Cancer.
[52] P. A. Sullivan. Vermiculite, Respiratory Disease, and Asbestos Exposure in Libby, Montana: Update of a Cohort Mortality Study , 2007, Environmental health perspectives.
[53] P. Fournel,et al. MN/CA9: a potential gene marker for detection of malignant cells in effusions , 2007, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.
[54] M. Spitz,et al. Dietary zinc, copper and selenium, and risk of lung cancer , 2006, International journal of cancer.
[55] J. Milner,et al. Diet and Cancer: Facts and Controversies , 2006, Nutrition and cancer.
[56] P. Sugarbaker,et al. Significance of lymph node metastasis in patients with diffuse malignant peritoneal mesothelioma. , 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[57] J. Rogers,et al. DNA methylation profiling of human chromosomes 6, 20 and 22 , 2006, Nature Genetics.
[58] G. Serio,et al. Cytogenetic and molecular genetic changes in malignant mesothelioma. , 2006, Cancer genetics and cytogenetics.
[59] S. Jhanwar,et al. Re-expression of the tumor suppressor NF2/merlin inhibits invasiveness in mesothelioma cells and negatively regulates FAK , 2006, Oncogene.
[60] G. Matullo,et al. Polymorphisms in DNA repair genes as risk factors for asbestos-related malignant mesothelioma in a general population study. , 2006, Mutation research.
[61] M. Neri,et al. Metabolic genotypes as modulators of asbestos-related pleural malignant mesothelioma risk: a comparison of Finnish and Italian populations. , 2006, International journal of hygiene and environmental health.
[62] Salih Emri,et al. Genetic predisposition to fiber carcinogenesis causes a mesothelioma epidemic in Turkey. , 2006, Cancer research.
[63] A. Cristaudo,et al. Medical surveillance of workers previously exposed to asbestos. , 2006, La Medicina del lavoro.
[64] P. Grandjean,et al. Prospective study of mesothelioma mortality in Turkish villages with exposure to fibrous zeolite. , 2006, Journal of the National Cancer Institute.
[65] W. Willett,et al. Intakes of vitamins A, C and E and folate and multivitamins and lung cancer: A pooled analysis of 8 prospective studies , 2006, International journal of cancer.
[66] M. Carbone,et al. The pathogenesis of mesothelioma. , 2006, Seminars in diagnostic pathology.
[67] Arturas Petronis,et al. Complex disease, gender and epigenetics , 2006, Annals of medicine.
[68] S. Bonassi,et al. Pleural malignant mesothelioma, genetic susceptibility and asbestos exposure. , 2005, Mutation research.
[69] S. Jhanwar,et al. A mouse model recapitulating molecular features of human mesothelioma. , 2005, Cancer research.
[70] M. Ladanyi. Implications of P16/CDKN2A deletion in pleural mesotheliomas. , 2005, Lung cancer.
[71] S. Jhanwar,et al. The NF2 Tumor Suppressor Gene Product, Merlin, Inhibits Cell Proliferation and Cell Cycle Progression by Repressing Cyclin D1 Expression , 2005, Molecular and Cellular Biology.
[72] Zhandong Liu,et al. Asbestos exposure, pleural mesothelioma, and serum osteopontin levels. , 2005, The New England journal of medicine.
[73] M. Baser,et al. Neurofibromatosis 2 (NF2) and Malignant Mesothelioma in a Man with a Constitutional NF2 Missense Mutation , 2005, Familial Cancer.
[74] K. Müller,et al. Factors influencing long-term survival in mesothelioma patients—results of the German mesothelioma register , 2004, International archives of occupational and environmental health.
[75] J. Tucker,et al. Sex chromosomes, micronuclei and aging in women , 1994, Chromosoma.
[76] A. Musk,et al. Mesothelin-family proteins and diagnosis of mesothelioma , 2003, The Lancet.
[77] Nea Malila,et al. Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up. , 2003, JAMA.
[78] Anne Janin,et al. Hemizygosity of Nf2 is associated with increased susceptibility to asbestos-induced peritoneal tumours , 2003, Oncogene.
[79] F. Forastiere,et al. The Protective Effect of the Mediterranean Diet on Lung Cancer , 2003, Nutrition and cancer.
[80] M. Ladanyi,et al. The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions , 2002, Cancer.
[81] A. Gazdar,et al. SV40 and human tumours: myth, association or causality? , 2002, Nature Reviews Cancer.
[82] F. Longo. Breast Cancer Conference , 2002 .
[83] L. Pitts,et al. Neurofibromatosis 2 and malignant mesothelioma. , 2002, Neurology.
[84] S. Emri,et al. Lung diseases due to environmental exposures to erionite and asbestos in Turkey. , 2002, Toxicology letters.
[85] M. Robinson,et al. Statement on malignant mesothelioma in the UK , 2002, Thorax.
[86] J. Testa,et al. p21-activated Kinase Links Rac/Cdc42 Signaling to Merlin* , 2002, The Journal of Biological Chemistry.
[87] Michael Huncharek,et al. Non-asbestos related diffuse malignant mesothelioma. , 2002, Tumori.
[88] R. Saracci,et al. Familial malignant mesothelioma , 2001, The Lancet.
[89] G. Melloni,et al. Therapeutic outcome according to histologic subtype in 121 patients with malignant pleural mesothelioma. , 2001, Lung cancer.
[90] S. Knuutila,et al. Genetic susceptibility and familial malignant mesothelioma , 2001, The Lancet.
[91] P De Vuyst,et al. Erionite bodies and fibres in bronchoalveolar lavage fluid (BALF) of residents from Tuzköy, Cappadocia, Turkey , 2001, Occupational and environmental medicine.
[92] J. Testa,et al. Genetic-susceptibility factor and malignant mesothelioma in the Cappadocian region of Turkey , 2001, The Lancet.
[93] A. Darnton,et al. The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure. , 2000, The Annals of occupational hygiene.
[94] F. McCormick,et al. Adenovirus-mediated p14(ARF) gene transfer in human mesothelioma cells. , 2000, Journal of the National Cancer Institute.
[95] P. Bidoli,et al. Malignant Mesothelioma in Subjects with Marfan’s Syndrome and Ehlers-Danlos Syndrome: Only an Apparent Association? , 2000, Respiration.
[96] M. Hande,et al. Accelerated telomere shortening in the human inactive X chromosome. , 1999, American journal of human genetics.
[97] V. Rusch,et al. Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically. , 1999, The Annals of thoracic surgery.
[98] J. Testa,et al. Asbestos, chromosomal deletions, and tumor suppressor gene alterations in human malignant mesothelioma , 1999, Journal of cellular physiology.
[99] J. Cheng,et al. Frequent mutations of NF2 and allelic loss from chromosome band 22q12 in malignant mesothelioma: Evidence for a two‐hit mechanism of NF2 inactivation , 1999, Genes, chromosomes & cancer.
[100] W. Richards,et al. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. , 1999, The Journal of thoracic and cardiovascular surgery.
[101] F. Nardi,et al. Familial pleural malignant mesothelioma: clustering in three sisters and one cousin. , 1998, Cancer letters.
[102] G. D. Guthrie,et al. Patterns of c-fos and c-jun proto-oncogene expression, apoptosis, and proliferation in rat pleural mesothelial cells exposed to erionite or asbestos fibers. , 1998, Toxicology and applied pharmacology.
[103] R. Kratzke,et al. Re-expression of p16INK4a in mesothelioma cells results in cell cycle arrest, cell death, tumor suppression and tumor regression , 1998, Oncogene.
[104] G. Giaccone,et al. Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[105] Cynthia K. Dohner. U.S. DEPARTMENT OF THE INTERIOR , 1998 .
[106] B. Price. Analysis of current trends in United States mesothelioma incidence. , 1997, American journal of epidemiology.
[107] K. Koskinen,et al. Glutathione S-transferase and N-acetyltransferase genotypes and asbestos-associated pulmonary disorders. , 1996, Journal of the National Cancer Institute.
[108] M R Cullen,et al. Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. , 1996, Journal of the National Cancer Institute.
[109] J. Surrallés,et al. Analysis of loss of inactive X chromosomes in interphase cells. , 1996, American journal of human genetics.
[110] L Kruglyak,et al. Parametric and nonparametric linkage analysis: a unified multipoint approach. , 1996, American journal of human genetics.
[111] J. Muscat,et al. Dietary intake and the risk of malignant mesothelioma. , 1996, British Journal of Cancer.
[112] D. Christiani,et al. Parental cancer and genetic predisposition in malignant pleural mesothelioma: a case-control study. , 1996, Cancer letters.
[113] P Dumortier,et al. An epidemiological study in an Anatolian village in Turkey environmentally exposed to tremolite asbestos. , 1996, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer.
[114] A. Demir,et al. Environmental fibrous zeolite (erionite) exposure and malignant tumors other than mesothelioma. , 1996, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer.
[115] S. Jhanwar,et al. High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[116] M. Huncharek. Genetic factors in the aetiology of malignant mesothelioma. , 1995, European journal of cancer.
[117] K. Pelin,et al. Inherited GSTM1 and NAT2 defects as concurrent risk modifiers in asbestos-related human malignant mesothelioma. , 1995, Cancer research.
[118] J. Minna,et al. Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer. , 1995, Cancer research.
[119] O. Olopade,et al. p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma. , 1994, Cancer research.
[120] A. Kamb. A cell cycle regulator potentially involved in genesis of many tumour types , 1994 .
[121] H. Hoogsteden,et al. Prognostic factors and survival in malignant pleural mesothelioma. , 1994, The European respiratory journal.
[122] D. Carson,et al. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers , 1994, Nature.
[123] M. Skolnick,et al. A cell cycle regulator potentially involved in genesis of many tumor types. , 1994, Science.
[124] G. Hannon,et al. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4 , 1993, Nature.
[125] A. Pollock. Human cancer: epidemiology and environmental causes , 1993 .
[126] S. Jhanwar,et al. Recurrent deletions of specific chromosomal sites in 1p, 3p, 6q, and 9p in human malignant mesothelioma. , 1993, Cancer research.
[127] J. Gouvernet,et al. Thoracoscopy in pleural malignant mesothelioma: A prospective study of 188 consecutive patients. Part 2: Prognosis and staging , 1993, Cancer.
[128] S. Franceschi,et al. Prognostic factors of malignant mesothelioma of the pleura , 1993, Cancer.
[129] L. Tammilehto. Malignant mesothelioma: prognostic factors in a prospective study of 98 patients , 1992 .
[130] K. Browne,et al. Familial mesothelioma. Details of 17 cases with histopathologic findings and mineral analysis , 1992, Cancer.
[131] B. Lanphear,et al. Latent period for malignant mesothelioma of occupational origin. , 1992, Journal of occupational medicine. : official publication of the Industrial Medical Association.
[132] M. Nebut,et al. Mesothelioma in rats following intrapleural injection of chrysotile and phosphorylated chrysotile (chrysophosphate) , 1992, International journal of cancer.
[133] V. Rusch,et al. The role of extrapleural pneumonectomy in malignant pleural mesothelioma. A Lung Cancer Study Group trial. , 1991, The Journal of thoracic and cardiovascular surgery.
[134] Baris Yi,et al. Fibrous zeolite (erionite)-related diseases in Turkey. , 1991 .
[135] Y. Bariş. Fibrous zeolite (erionite)-related diseases in Turkey. , 1991, American journal of industrial medicine.
[136] T. Sigsgaard,et al. [Massive exposure to asbestos and malignant mesothelioma, familial accumulation]. , 1990, Ugeskrift for laeger.
[137] T. H. van der Kwast,et al. Cytogenetic analysis of malignant mesothelioma. , 1990, Cancer genetics and cytogenetics.
[138] J. Testa,et al. Recurring loss involving chromosomes 1, 3, and 22 in malignant mesothelioma: Possible sites of tumor suppressor genes , 1989, Genes, chromosomes & cancer.
[139] R. Ginsberg,et al. Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[140] Frederick P. Li,et al. ASBESTOS-CONTAMINATED NAPPIES AND FAMILIAL MESOTHELIOMA , 1989, The Lancet.
[141] S. Hammar,et al. Familial mesothelioma: a report of two families. , 1989, Human pathology.
[142] D. Williams,et al. Malignant mesothelioma of the pleura. , 1988, Mayo Clinic proceedings.
[143] S. P. D. León,et al. Mesotelioma pleural maligno familiar. Informe de tres casos , 1988 .
[144] S. Knuutila,et al. Nonrandom chromosomal abnormalities in malignant pleural mesothelioma. , 1988, Cancer genetics and cytogenetics.
[145] L. Pickle,et al. Case-control study of diet and mesothelioma in Louisiana. , 1988, Cancer research.
[146] M. Tucker,et al. Survival patterns for malignant mesothelioma: The seer experience , 1988, International journal of cancer.
[147] J. DiPaolo,et al. Nonrandom chromosome alterations in human malignant mesothelioma. , 1988, Cancer research.
[148] R. Shemin,et al. Malignant mesothelioma: prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women's Hospital experience over two decades, 1965-1985. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[149] O. Mutchinick,et al. [Familial malignant pleural mesothelioma. Report of 3 cases]. , 1988, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion.
[150] S. Knuutila,et al. Chromosomal abnormalities in malignant pleural mesothelioma , 1987 .
[151] L. Simonato,et al. Epidemiological and environmental evidence of the health effects of exposure to erionite fibres: A four‐year study in the cappadocian region of turkey , 1987, International journal of cancer.
[152] E. Borden,et al. Randomized comparison of cyclophosphamide, imidazole carboxamide, and adriamycin versus cyclophosphamide and adriamycin in patients with advanced stage malignant mesothelioma: a Sarcoma Intergroup Study. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[153] R. Stahel,et al. Chromosome changes in malignant mesothelioma. , 1986, Cancer genetics and cytogenetics.
[154] R. J. Hill,et al. Erionite exposure and mesotheliomas in rats. , 1985, British Journal of Cancer.
[155] H. Lynch,et al. Familial mesothelioma: review and family study. , 1985, Cancer genetics and cytogenetics.
[156] N. Johnson,et al. Pluripotential nature of mesotheliomata induced by inhalation of erionite in rats. , 1984, British journal of experimental pathology.
[157] G. Mårtensson,et al. Malignant mesothelioma in two pairs of siblings: is there a hereditary predisposing factor? , 1984, European journal of respiratory diseases.
[158] Ramon Silva Martins,et al. Malignant pleural mesothelioma. , 2012, Journal of the National Comprehensive Cancer Network : JNCCN.
[159] C. Maltoni,et al. Pleural mesotheliomas in Sprague-Dawley rats by erionite: first experimental evidence. , 1982, Environmental research.
[160] D. Crowther,et al. Cancer—Principles and Practice of Oncology. V , 1982, British Journal of Cancer.
[161] L. Norton,et al. Diffuse malignant mesothelioma. Prospective evaluation of 69 patients. , 1982, Annals of internal medicine.
[162] A. Langer,et al. Endemic pleural disease associated with exposure to mixed fibrous dust in Turkey. , 1982, Science.
[163] V. Devita,et al. Cancer : Principles and Practice of Oncology , 1982 .
[164] L. Simonato,et al. MALIGNANT MESOTHELIOMA AND RADIOLOGICAL CHEST ABNORMALITIES IN TWO VILLAGES IN CENTRAL TURKEY An Epidemiological and Environmental Investigation , 1981, The Lancet.
[165] J. Bignon,et al. Zeolite bodies in human lungs from Turkey. , 1981, Laboratory investigation; a journal of technical methods and pathology.
[166] J. Nickels,et al. Familial clustering of malignant mesothelioma , 1980, Cancer.
[167] E. W. Shaw,et al. Department of the Interior , 1986, The Bulletin of the Ecological Society of America.
[168] M. Artvinli,et al. ENVIRONMENTAL MESOTHELIOMA IN TURKEY , 1979, Annals of the New York Academy of Sciences.
[169] J. Abbatt. History of the use and toxicity of thorotrast. , 1979, Environmental research.
[170] J. Lokich,et al. Familial mesothelioma after intense asbestos exposure at home. , 1978, JAMA.
[171] Y. Bariş,et al. An outbreak of pleural mesothelioma and chronic fibrosing pleurisy in the village of Karain/Urgüp in Anatolia. , 1978, Thorax.
[172] G. B. Gori,et al. Contribution of the environment to cancer incidence: an epidemiologic exercise. , 1977, Journal of the National Cancer Institute.
[173] W Schmid,et al. The micronucleus test. , 1975, Mutation research.
[174] J. Wagner,et al. Diffuse Pleural Mesothelioma and Asbestos Exposure in the North Western Cape Province , 1960, British journal of industrial medicine.
[175] K. Sirola. Malignant mesothelioma of the pleura. , 1959, Annales chirurgiae et gynaecologiae Fenniae.